UTP23 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.623800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.258800E-01
Normal-vs-Stage2
5.238200E-01
Normal-vs-Stage3
1.316230E-01
Normal-vs-Stage4
6.933800E-01
Stage1-vs-Stage2
4.581400E-01
Stage1-vs-Stage3
1.352020E-01
Stage1-vs-Stage4
5.416800E-01
Stage2-vs-Stage3
3.202400E-01
Stage2-vs-Stage4
1.095780E-01
Stage3-vs-Stage4
2.190800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.417400E-01
Normal-vs-AfricanAmerican
7.381400E-01
Normal-vs-Asian
4.391200E-01
Caucasian-vs-AfricanAmerican
7.898400E-01
Caucasian-vs-Asian
5.186400E-01
AfricanAmerican-vs-Asian
5.721400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.368800E-01
Normal-vs-Female
6.197200E-01
Male-vs-Female
5.364200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.599400E-01
Normal-vs-Age(41-60Yrs)
9.532200E-01
Normal-vs-Age(61-80Yrs)
4.344200E-01
Normal-vs-Age(81-100Yrs)
3.189600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.023800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.410800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.785400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.158400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.233840E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.438200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.394020E-01
Normal-vs-Daily Drinker
3.499600E-01
Normal-vs-Weekly Drinker
2.520600E-01
Normal-vs-Occasional Drinker
7.191200E-01
Normal-vs-Social Drinker
6.727400E-01
Non Drinker-vs-Daily Drinker
8.221000E-01
Non Drinker-vs-Weekly Drinker
9.216800E-01
Non Drinker-vs-Occasional Drinker
3.841200E-03
Non Drinker-vs-Social Drinker
1.662990E-01
Daily Drinker-vs-Weekly Drinker
8.146800E-01
Daily Drinker-vs-Occasional Drinker
1.584260E-02
Daily Drinker-vs-Social Drinker
3.679000E-01
Weekly Drinker-vs-Occasional Drinker
1.443820E-02
Weekly Drinker-vs-Social Drinker
2.850800E-01
Occasional Drinker-vs-Social Drinker
1.689370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.332600E-01
Normal-vs-Grade 2
2.697400E-01
Normal-vs-Grade 3
2.284400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.773000E-01
Grade 1-vs-Grade 3
3.455800E-01
Grade 1-vs-Grade 4
4.332600E-01
Grade 2-vs-Grade 3
2.189200E-01
Grade 2-vs-Grade 4
2.697400E-01
Grade 3-vs-Grade 4
2.284400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.687200E-01
Normal-vs-NonDiabetic
4.512400E-01
Diabetic-vs-NonDiabetic
8.223600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.959820E-01
Normal-vs-NoPancreatitis
5.002400E-01
Pancreatitis-vs-NoPancreatitis
3.567600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.814000E-01
Normal-vs-N1
5.580600E-01
N0-vs-N1
9.827800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.085600E-01
Normal-vs-TP53-NonMutant
7.084800E-01
TP53-Mutant-vs-TP53-NonMutant
1.088360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
